Latest filing published 28 Sept 2026 for Lexeo Therapeutics, Inc., €4,813.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Jose Manuel Otero on record concern Lexeo Therapeutics, Inc. The record holds 14 filings, for trades running from 12 June 2024 to 14 September 2026.
No open-market purchase appears, only 7 sales worth €61k. Outside the open market, there are 7 share grants. So far in 2026, the count stands at no purchases and 3 sales.
The record was last updated on 28 September 2026 with a share grant (€4,813) in Lexeo Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations